OPEN END TURBO OHNE STOP-LOSS - VIVORYON THERAPEUTICS | Market Closed - Börse Stuttgart 07:13:24 28/06/2024 pm IST | ||
| 1.42 EUR | +69.05% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VIVORYON THERAPEUTICS N.V.
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 1.42 | +69.05% |
| 27/24/27 | 0.84 | -14.29% |
| 26/24/26 | 0.98 | -20.33% |
| 25/24/25 | 1.23 | -3.91% |
| 24/24/24 | 1.28 | -5.19% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 07:13 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | VIVORYON THERAPEUTICS N.V. |
| Issuer | Lang & Schwarz |
| WKN | LX39G9 |
| ISIN | DE000LX39G98 |
| Date issued | 05/06/2024 |
| Strike | 1.055 € |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 1.85 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.34 € |
|---|---|
| Lowest since issue | 0.84 € |
Company Profile
Vivoryon Therapeutics N.V. specializes in the research and development of therapeutic products for the treatment of Alzheimer disease.
At the end of 2023, the group has a portfolio of a product in phase II-B clinical development (Varoglutamstat; PQ912).
Sector
-
Consensus: Vivoryon Therapeutics N.V.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1.85
EUR
Average target price
41.57
EUR
Spread / Average Target
+2,146.85%
- Stock Market
- Certificates
- Certificat
